...
机译:CYP2D6和CYP3A4基因型对南方患者阿尔茨海默病患者胆碱酯酶抑制剂的疗效
Chinese Univ Hong Kong Fac Med Dept Psychiat Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Dept Chem Pathol Hong Kong Peoples R China;
Kwai Chung Hosp Hong Kong Peoples R China;
Kwai Chung Hosp Hong Kong Peoples R China;
Queen Mary Hosp Hong Kong Peoples R China;
Princess Margaret Hosp Hong Kong Peoples R China;
Princess Margaret Hosp Hong Kong Peoples R China;
North Dist Hosp Hong Kong Peoples R China;
Kowloon Hosp Hong Kong Peoples R China;
Ruttonjee Hosp Hong Kong Peoples R China;
Ruttonjee Hosp Hong Kong Peoples R China;
Ruttonjee Hosp Hong Kong Peoples R China;
Kwong Wah Hosp Hong Kong Peoples R China;
Queen Mary Hosp Hong Kong Peoples R China;
Chinese Univ Hong Kong Fac Med Dept Psychiat Hong Kong Peoples R China;
Alzheimer's disease; donepezil; efficacy; pharmacogenetics; tolerability;
机译:CYP2D6和CYP3A4基因型对南方患者阿尔茨海默病患者胆碱酯酶抑制剂的疗效
机译:胆碱酯酶抑制剂治疗的阿尔茨海默氏病患者的BCHE和CYP2D6遗传变异。
机译:胆碱酯酶抑制剂治疗的阿尔茨海默病患者的BCHE和CYP2D6遗传变异
机译:在阿尔茨海默病的胆碱酯酶抑制剂治疗中提高依从性和持续性:Caretocare的发展?护理人员支持计划
机译:胆碱酯酶抑制剂对阿尔茨海默氏病的回顾性研究:脑血管疾病对患者结果的影响以及偏见对结果的影响。
机译:NEuroaid(ATHENE)研究阿尔茨海默氏病的研究方案:评估神经碱II(MLC901)在胆碱酯酶抑制剂或美金刚稳定的轻度至中度阿尔茨海默氏病患者中的安全性和有效性-随机,双盲,安慰剂对照试用
机译:Lzheimer的疾病与Ne Uroaid(Athene)的研究方案的脱脂剂:评估神经外套II(MLC901)在胆碱酯酶抑制剂或Memantine-A随机的双盲患者稳定的患者中神经外套II(MLC901)的安全性和有效性安慰剂对照试验